Ardelyx (ARDX) vs Attovia Therapeutics (ATTO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Ardelyx is the larger company by market cap ($844.3 million vs $744.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARDX | ATTO |
|---|---|---|
| Share price | $3.27 | $16.31 |
| Market cap | $844.27M | $744.57M |
| 1-day change | +0.31% | -0.67% |
| YTD return | -43.91% | — |
| 1-year return | -35.38% | — |
| 5-year return | +202.78% | — |
| Forward P/E | 11.26 | — |
| EPS (TTM) | $-0.23 | $-2.74 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.40 | $28.00 |
| 52-week low | $3.18 | $15.48 |
| Distance from 52-week high | -61.07% | -41.75% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +294.50% | +158.74% |
| Average volume | 4.17M | 457.37K |
| Shares outstanding | 258.19M | 45.65M |
| Employees | 489 | 44 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Ardelyx
ARDX stock →Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
Healthcare · Biotechnology · 489 employees
About Attovia Therapeutics
ATTO stock →Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments.
Healthcare · Biotechnology · 44 employees
ARDX vs ATTO FAQ
Which is bigger, Ardelyx or Attovia Therapeutics?
Ardelyx (ARDX) is larger, with a market capitalization of $844.27M compared with $744.57M for Attovia Therapeutics (ATTO).
Are Ardelyx and Attovia Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.